155
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding

, PharmD, , PhD, , MD, , BSc, , MSc, , MD & , PharmD show all
Pages 2281-2290 | Published online: 10 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David F Archer & Ian S Fraser. (2013) An expert review and commentary on the efficacy and safety of tranexamic acid for the treatment of heavy menstrual bleeding. Expert Review of Obstetrics & Gynecology 8:6, pages 499-511.
Read now

Articles from other publishers (5)

Richard A. Graham, Ilsung Chang, Jin Yan Jin, Bei Wang, Matthew B. Dufek, Jean A. Ayache, Farkad Ezzet, Kenn Zerivitz, Jennifer A. Low & Mark J. Dresser. (2013) Daily Dosing of Vismodegib to Steady State Does Not Prolong the Qtc Interval in Healthy Volunteers. Journal of Cardiovascular Pharmacology 61:1, pages 83-89.
Crossref
Lisa PerrieraJanet MartinSanjay P. Ahuja. (2012) Reducing Heavy Menstrual Bleeding: Safety and Efficacy of Tranexamic Acid. Clinical Medicine Insights: Women's Health 5, pages CMWH.S6314.
Crossref
Jill S. Bates, Larry W. Buie & C. Brock Woodis. (2012) Management of Menorrhagia Associated with Chemotherapy‐Induced Thrombocytopenia in Women with Hematologic Malignancy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:11, pages 1092-1110.
Crossref
Jørgen Matz, Claus Graff, Petri J. Vainio, Antero Kallio, Astrid Maria Højer, Johannes J. Struijk, Jørgen K. Kanters, Mads P. Andersen & Egon Toft. (2012) Effect of Nalmefene 20 and 80 mg on the Corrected QT Interval and T-Wave Morphology. Clinical Drug Investigation 31:11, pages 799-811.
Crossref
Andrea S Lukes, Peter A Kouides & Keith A Moore. (2011) Tranexamic Acid: A Novel Oral Formulation for the Treatment of Heavy Menstrual Bleeding. Women's Health 7:2, pages 151-158.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.